Strategic Pivot: How Innovative Therapies Are Transforming the US Lung Cancer Market
The US lung cancer market is poised for significant expansion, projected to reach a market size of USD 18 billion by 2035, growing at a compound annual growth rate (CAGR) of 7.65%. This growth trajectory reflects a paradigm shift in treatment methodologies and a surge in market demand driven by innovative therapies and heightened patient awareness. As the incidence of lung cancer continues to...
0 Σχόλια 0 Μοιράστηκε 4 Views 0 Προεπισκόπηση